Lantern Pharma Inc. (LTRN) Stock price, Description, News & Info

#ThinkSabio Latest News

Lantern Pharma’s LP-184 Shows Promising In Vivo Activity in Atypical Teratoid Rhabdoid Tumors (ATRT) at SNO Pediatric Conference, Further Validating Rare Pediatric Disease Designation and Pathway to Clinical Trials

Light
Dark